Functional Cognitive Disorder: Memory Symptoms, Diagnosis, and Care
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
What Is Functional Cognitive Disorder?
Functional cognitive disorder (FCD) describes persistent and often disabling problems with memory, attention, concentration, or other cognitive abilities, together with clinical evidence that cognitive performance varies in a characteristic way across situations or tasks. The central diagnostic idea is internal inconsistency: an ability may work relatively well automatically or in one context yet become difficult when the person deliberately tries to use or monitor it. The symptoms are experienced as real and can substantially interfere with work, conversation, study, relationships, and confidence. FCD is assessed through a neurological and cognitive evaluation, with positive features interpreted alongside appropriate consideration of other causes. The term is increasingly used in specialized memory and neurology services. See the 2019 systematic review and the 2023 clinical review.
FCD is a developing clinical construct. Researchers have proposed operational diagnostic criteria, but these criteria have not yet undergone the external validation needed to establish a universally accepted independent diagnostic standard. It is not a separate, formally listed diagnosis in DSM-5-TR. Its relationship to functional neurological disorder (FND), subjective cognitive decline, psychiatric presentations, and other cognitive syndromes is a subject of continuing research. The 2025 international Delphi study demonstrated disagreement in terminology and clinical decisions among experienced specialists. Readers should therefore understand FCD as a clinically useful diagnostic formulation whose boundaries and measurement tools are still being refined.
What Do Functional Cognitive Symptoms Feel Like?
Many people describe knowing that a word, name, intention, or familiar fact is available but being unable to retrieve it when they want it. They may enter a room and forget why, lose the thread of a conversation, reread sentences, struggle to concentrate in noisy settings, or feel unusually effortful and mentally slow. A person may repeatedly check whether they have forgotten something, worry about making errors at work, or begin to distrust their memory. These experiences are meaningful even when standardized cognitive scores are reassuring. Reviews of functional cognitive symptoms describe attentional lapses, subjective word-finding difficulty, disrupted confidence, and a sense of cognitive inefficiency among common presentations. See McWhirter and Carson.
Symptoms differ between people and fluctuate within the same person. Fatigue, multitasking, sleep disruption, pain, illness, sensory overload, and pressure to perform can change how cognition feels and how well a task is completed. Some patients describe a severe discrepancy between what they expect from their memory and what they believe they achieve. Others have observable cognitive difficulties in certain circumstances. These descriptions help clinicians ask targeted questions, but none is individually diagnostic: ordinary distraction, depression, ADHD, medication effects, neurodegenerative disease, and many other conditions can also produce similar complaints.
Memory, attention, language, and executive function
The complaint that sounds like poor memory may originate in difficulty directing attention when information is first encountered. If someone listens while preoccupied, the information may never be encoded clearly enough to remember later. Word-finding problems, losing a plan mid-task, and reduced mental stamina can be part of the same experience. Clinicians distinguish encoding, storage, retrieval, processing speed, and executive control through history and, where useful, formal assessment. No single cognitive symptom identifies FCD, and apparently reassuring memory test results do not invalidate the person's report.
Impact on daily life
Functional cognitive symptoms can lead to missed appointments, unfinished tasks, repeated reassurance seeking, reduced social participation, workplace errors, and avoidance of demanding activities. People sometimes stop using abilities that remain available because they fear the consequences of a lapse. A careful assessment considers actual changes in independent living, medication management, finances, driving, and safety as well as distress. The degree of impairment, support needed, and trajectory matter more clinically than the intensity of worry alone.
How Is Functional Cognitive Disorder Diagnosed?
A clinician develops a diagnosis from the complete pattern of symptoms, the neurological examination, cognitive observations, relevant tests, medical history, and changes over time. The focus is on whether there are positive clinical features of a functional cognitive presentation and whether a competing condition better explains the findings. FCD should not be diagnosed solely because brain imaging is normal or because laboratory investigations have not identified a cause. Normal tests may be compatible with FCD, but can also occur early in some neurological conditions. The 2023 diagnostic systematic review and meta-analysis evaluated the evidence for specific observable signs and emphasized the need for stronger diagnostic validation.
Internal inconsistency: the central positive feature
Internal inconsistency means a meaningful difference between performance that should draw on the same cognitive ability in different contexts. For example, a patient may describe being unable to remember conversations while readily recounting the details of earlier appointments; or perform a demanding conversation effectively while reporting that simpler tasks become inaccessible when consciously tested. Such patterns may suggest a functional mechanism, especially when they are reproducible and interpreted by an experienced clinician. Inconsistency does not imply dishonesty, deliberate underperformance, or that symptoms are insignificant. It is one piece of a wider clinical formulation, not a home test or proof against coexisting neurological disease.
Specialists distinguish inconsistency from expected variation caused by fatigue, pain, mood, sleep, sensory problems, language barriers, education, test anxiety, and fluctuation within known neurological disorders. A person's ability to describe a memory concern in detail, to attend alone, or to bring an organized symptom list has appeared among research-level clues, but such behavior is not a definitive diagnostic sign and must never be used to rule out dementia by itself. The 2023 meta-analysis found encouraging but heterogeneous evidence, while the 2025 checklist development study presented an initial tool rather than a fully validated standard.
Proposed diagnostic criteria and their current status
Frequently cited proposed FCD criteria ask clinicians to establish: one or more cognitive symptoms; positive clinical evidence of internal inconsistency; symptoms not better explained by another medical or psychiatric condition; and distress, impairment, or sufficient concern to warrant medical evaluation. These proposals are research-based and clinically influential. They remain proposed criteria, with limited external validation and uncertain reliability across populations and settings. An international expert Delphi study reported a wide range of diagnostic labels and management decisions across clinical vignettes, underlining the importance of careful case formulation.
A 2025 multicenter pilot checklist study developed full and shortened checklists using expert consensus and patients from memory services. Its accuracy findings are preliminary, since diagnostic thresholds and generalizability require independent testing. The 2026 scoping review of neuropsychological assessment likewise reported heterogeneous performance and an absence of a standalone cognitive test with diagnostic specificity for FCD. Checklists can structure clinical thinking; they are not a self-diagnostic instrument.
What Happens During a Memory or Neurology Assessment?
The first step is an account of what changed, when it began, whether the change is progressing, which abilities are affected, and how much daily independence has changed. The clinician asks about concrete examples and the circumstances in which problems become better or worse. With consent, information from a family member, close friend, or another person who knows the individual's previous functioning can be valuable. A careful history reviews neurological and medical conditions, head injuries, sleep, mood, anxiety, substance use, hearing and vision, prescription and nonprescription medication, and the person's language and educational background. The Alzheimer's Association primary-care guideline recommends a structured evaluation of cognitive concerns.
Cognitive screening may use a validated brief instrument, but its scores must be interpreted in context. A normal screening score cannot guarantee the absence of mild impairment, while a low score cannot independently establish neurodegeneration or FCD. The clinician may assess attention, verbal learning, delayed recall, recognition, language, executive function, visuospatial abilities, neurological signs, and practical functioning. A detailed neuropsychological evaluation is particularly useful when symptoms and office testing appear discordant, impairment is subtle, or the medical picture is complex. The specialty-care diagnostic guideline provides a tiered approach and explains when further testing is appropriate.
Blood work, imaging, or other investigations are selected according to history, examination, age, risks, and clinical indications. The clinician may review metabolic and endocrine causes, nutritional problems, medication effects, sleep apnea, inflammatory or neurological disorders, and other treatable contributors. Structural imaging may be important in some situations, but a normal MRI alone does not confirm FCD. Alzheimer's disease biomarkers, specialist imaging, or other advanced testing are reserved for appropriate clinical questions and require expert interpretation. Repeated testing without a clear purpose can increase distress and produce incidental findings, so clinicians should explain what each investigation would change.
Functional Cognitive Disorder vs Dementia, Mild Cognitive Impairment, and Subjective Cognitive Decline
FCD and neurodegenerative disease can present with similar complaints, particularly early in an illness. A person with FCD may be intensely concerned by memory lapses while demonstrating preserved abilities on some tasks. In some dementias, changes become progressively more apparent to relatives and interfere with independent daily activities, although individual courses and insight vary considerably. These are probabilistic clues rather than rules: a person with a neurodegenerative disorder can describe symptoms precisely, worry greatly, and retain substantial independence. Conversely, FCD can produce serious disability. The longitudinal pattern, corroborated functional change, examination, and appropriate testing are essential.
FCD and subjective cognitive decline
Subjective cognitive decline describes a person's experience of worsening cognition despite performance remaining within the expected range on formal testing. It is a descriptive research and clinical construct with multiple possible explanations, not automatically FCD. Functional mechanisms may explain some cases, while others may relate to sleep, psychiatric or medical factors, aging, or early neurodegenerative processes. FCD requires a more specific formulation involving positive functional features, rather than subjective concern alone. The Alzheimer's Association diagnostic guidance emphasizes characterizing the cognitive syndrome and its likely causes before drawing conclusions.
FCD and mild cognitive impairment
Mild cognitive impairment (MCI) involves measurable cognitive decline greater than expected for an individual in the relevant clinical context without the level of loss of independence that defines dementia. It has diverse causes and does not necessarily progress to dementia. Some patients with FCD perform below expected ranges on isolated cognitive tests, and some with MCI show inconsistency or concurrent functional symptoms. Thus test performance and diagnostic terminology alone should not be treated as mutually exclusive. Specialist assessment can identify the pattern of learning, recall, recognition, executive function, and daily abilities.
FCD and dementia
Dementia is a syndrome involving cognitive decline that interferes with independence and is attributable to a range of brain diseases. Evaluation seeks evidence of a consistent cognitive–behavioral syndrome and likely cause, including Alzheimer's disease, vascular, Lewy body, frontotemporal, or other conditions. Progressive loss of everyday skills, worsening neurological signs, or new changes witnessed by others require renewed assessment even when FCD was previously diagnosed. A functional formulation does not create immunity from acquiring another illness later. Clinicians should communicate the reasoning behind the current diagnosis and a plan for review.
Other Conditions That Can Resemble or Coexist With FCD
Depression may affect motivation, processing speed, concentration, and memory confidence; anxiety can heighten monitoring of errors and interfere with attention. Insomnia and sleep apnea can markedly disrupt cognition. ADHD and learning differences can explain lifelong attention patterns, while migraine, chronic pain, fatigue syndromes, post-concussion states, medication adverse effects, alcohol or other substances, endocrine disorders, nutritional deficiencies, and sensory impairment can contribute in different ways. Long COVID and other postinfectious conditions can include cognitive complaints that require individualized medical assessment. Patients may have more than one contributor, and treating an accompanying condition is useful even when functional cognitive features are also present.
Functional cognitive symptoms may coexist with motor, sensory, or seizure-like manifestations discussed within functional neurological disorder. However, the evidence for functional movement symptoms or functional seizures cannot automatically be applied to cognition. A history of trauma is neither a required criterion nor an established individual cause of FCD. Dissociation, PTSD, panic, obsessive doubts about memory, depression, and neurological diseases deserve their own assessment when relevant. In particular, inferring fabrication or intentional deception from an inconsistent examination would be a serious clinical error.
Why Can Functional Cognitive Symptoms Develop?
Several models attempt to explain how cognition becomes effortful and unreliable. One involves attention: when attention is diverted toward checking memory performance, normal automatic processes can become disrupted. Another concerns metacognition, the ability to monitor and evaluate one's own thinking: a person may experience ordinary slips as evidence of global deterioration and begin to underestimate their actual abilities. Expectations, learned threat associations, and repeated self-testing may amplify perceived cognitive failures. These are plausible explanatory mechanisms supported by developing research, rather than proven universal causes. The 2026 integrative review describes competing and complementary frameworks.
Attention, self-monitoring, and expectations
Many cognitive tasks work best when attention is directed toward the task rather than the act of remembering. A person who closely monitors every word or checks each mental step may find thinking less fluent, which can reinforce worry and additional checking. Over time, changes in confidence and activity may sustain difficulty. This account can inform an individualized formulation and treatment discussion; it should not be applied rigidly to every patient. Differences in cognitive reserve, medical burden, fatigue, and underlying neurological function alter the picture.
Stress, mood, pain, and sleep
Stress, worry, mood symptoms, pain, and poor sleep may contribute to cognitive inefficiency and distress, and these factors frequently coexist with FCD. Their presence does not establish causation. A person may develop symptoms without a clear stressor, and an identified life event does not prove the mechanism of the cognitive complaint. The clinically useful question is which contributors can be treated or accommodated now and whether another disorder requires specific investigation. The functional cognitive clinical review emphasizes individualized formulation and recognition of secondary causes.
Treatment and Care: What Is Supported by Evidence?
Care begins with a comprehensible explanation of the diagnosis and a shared plan addressing symptoms, function, uncertainty, and follow-up. A useful explanation names the positive clinical findings supporting the current formulation, reviews tests already performed, identifies any additional investigations that are warranted, and explains why functional symptoms can be genuine and disabling. Treatment should reflect the individual's actual cognitive tasks, comorbidities, goals, preferences, and risk profile. No medication has been established as a specific cure for FCD, and high-quality treatment trials remain limited. The 2023 management review describes promising psychotherapeutic and metacognitive approaches while acknowledging the evidence gap.
Cognitive behavioral and metacognitive approaches
Condition-focused psychological treatment may help people change catastrophic interpretations of lapses, reduce counterproductive monitoring or checking, rebuild confidence, and resume avoided cognitive activities. Cognitive behavioral therapy (CBT) and metacognitive retraining can target attention, memory beliefs, anxiety, and behavior, but standardized FCD protocols have a developing evidence base. A 2024 pilot randomized feasibility trial studied CBT tailored to functional cognitive difficulties after concussion and compared it with cognitive rehabilitation. Its small sample and specific post-concussion population mean that findings cannot establish a broadly effective treatment for all FCD.
Practical rehabilitation and daily strategies
Occupational or cognitive rehabilitation can help with task planning, pacing, routines, and demands at school or work. Some people benefit from a consistent calendar, fewer simultaneous tasks, a distraction-reduced workspace, realistic breaks, sleep scheduling, and a gradual return to valued activities. These strategies are tools for function, not evidence that memory is permanently impaired. Clinicians may examine whether excessive reminders, repeated checking, or constant self-testing are making day-to-day performance more burdensome. The balance between helpful compensation and unhelpful monitoring must be individualized rather than imposed as a universal rule.
Treating accompanying conditions
Treatment of depression, anxiety, insomnia, sleep apnea, pain, medication adverse effects, or other diagnosed conditions may improve the overall cognitive burden. Medication decisions should be made for the relevant condition and reviewed for cognitive side effects; patients should not stop prescribed medicines independently. Where several professionals are involved, coordinated care reduces conflicting advice and repeated investigations. Follow-up should assess both the person's experienced difficulty and observable changes in daily function.
Prognosis: Does FCD Go Away or Progress to Dementia?
Many people with functional cognitive symptoms experience a stable or fluctuating course, and some improve after explanation, changes in daily demands, or targeted treatment. Yet the certainty of an individual prognosis is limited. FCD cohorts vary in how patients are selected, how diagnoses are made, the length of follow-up, and whether coexisting diseases are present. Long-term prospective validation is still an important research gap. A 2025 overview discusses often favorable trajectories, while earlier systematic research emphasizes the risks of both overpredicting decline and prematurely dismissing disease.
A diagnosis of FCD does not mean a patient can never develop dementia, another neurological condition, or a new medical problem. Nor does persistent cognitive difficulty automatically mean neurodegeneration. The appropriate approach is longitudinal: document a baseline, agree on follow-up, and repeat targeted evaluation when symptoms progress, daily independence changes, or new neurological features emerge. Researchers should avoid claiming that conversion to dementia is impossible, because diagnostic methods and long-term outcome studies remain insufficient for that absolute conclusion.
When to Seek Urgent Medical Assessment
Sudden confusion or memory loss accompanied by new weakness, facial drooping, speech disturbance, severe headache, collapse, seizure, high fever, significant head injury, or rapidly worsening awareness requires prompt urgent medical evaluation. Acute changes can reflect stroke, infection, seizures, toxic or metabolic disturbances, medication effects, or other serious conditions. An earlier FCD diagnosis should never be used to explain away a new emergency. For a slower but clear progression in cognition or growing loss of daily independence, arrange timely medical reassessment rather than relying on an old diagnostic label.
How to Prepare for an Appointment
Bring a concise timeline of when symptoms began, whether they have progressed, examples of tasks that are difficult, sleep and medication details, other health concerns, and what has changed at home, school, or work. Include situations in which thinking feels easier or harder. If comfortable, invite someone who can describe changes they have observed. Ask the clinician which findings support the proposed diagnosis, what alternatives have been considered, whether additional testing would change management, how coexisting conditions will be addressed, and when to return if problems worsen. The purpose is a shared medical assessment, not persuading the clinician toward a predetermined label.
Frequently Asked Questions
Is functional cognitive disorder real?
Yes. Cognitive complaints and disability can be genuine even when conventional scans or some standardized tests are reassuring. The diagnosis refers to a particular clinical pattern and possible functional mechanisms. The proposed criteria and tools continue to be refined, so it is appropriate for clinicians to explain the level of diagnostic certainty and review plans.
Does FCD mean I have dementia?
No. FCD is a different clinical formulation, and neither the intensity of memory worry nor one cognitive score establishes dementia. Clinicians evaluate progression, independence, neurological findings, corroborating history, and testing. If clear changes emerge later, they warrant assessment.
Can functional cognitive symptoms occur with another disease?
Yes. A person may have functional cognitive symptoms alongside depression, sleep disorders, chronic pain, neurological illness, or other medical conditions. Clinicians must consider the relative contribution of each and avoid assuming that one diagnosis explains everything.
Can an MRI or blood test prove FCD?
There is no single routine imaging or laboratory finding that proves FCD. Tests can identify other causes or clarify the differential according to clinical need. Positive functional clinical findings remain important, but no sign or questionnaire independently determines the diagnosis.
Is FCD caused by anxiety or trauma?
Anxiety, mood disturbance, stress, pain, sleep disruption, and other factors may contribute to or accompany symptoms, but they are not universal causes or mandatory diagnostic requirements. The presence or absence of trauma alone cannot determine whether someone has FCD.
Is there a treatment that works for everyone?
No universally established FCD-specific treatment protocol exists. Education, coordinated medical assessment, targeted psychotherapy, metacognitive strategies, and functional rehabilitation can be appropriate depending on the case. Treatment evidence, especially large randomized trials and durable outcomes, remains limited.
Can I diagnose FCD with an online checklist?
No. Research checklists are being developed, but they cannot substitute for clinical history, examination, differential diagnosis, and individualized judgment. The 2025 checklist study is promising preliminary research, not a validated personal diagnostic test.
When should I ask for another assessment?
Seek renewed evaluation if cognitive symptoms clearly worsen, independent daily tasks become harder, new neurological signs appear, or the current explanation no longer fits the course. Sudden focal neurological symptoms or acute confusion require urgent assessment.
Related Articles
For related context, read Somatic Symptom and Functional Disorders.
For related context, read Functional Neurological Disorder.
For related context, read Positive Signs and Medical Assessment.
For related context, read Functional Neurological Disorder Treatment.
For related context, read What Causes Functional Neurological Disorder?.
For related context, read Depression and Brain Fog.
For related context, read Sleep and Memory.
What the Evidence Still Needs to Establish
The strongest available evidence helps describe clinical features and encourages positive, respectful assessment. Important uncertainties remain: how reliably different clinicians can recognize FCD, how validated tools perform outside specialist memory services, which patient groups respond to particular treatments, how to distinguish mixed functional and neurodegenerative presentations, and which findings best predict long-term outcome. The 2023 meta-analysis, 2025 Delphi and checklist studies, and 2026 neuropsychological scoping review should be read as steps in the development of evidence-based practice. Clinical care must integrate their findings with established standards of medical cognitive assessment.
References
Alzheimer's Association. (2025). Clinical practice guideline: Diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders, primary care. Alzheimer's & Dementia.
Alzheimer's Association. (2025). Clinical practice guideline: Diagnostic evaluation, testing, counseling, and disclosure, specialty care. Alzheimer's & Dementia.
Aybek, S., & Perez, D. L. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64.
Ball, H. A., et al. (2020). Functional cognitive disorder: Dementia's blind spot. Brain, 143, 2895–2903.
Cabreira, V., et al. (2023). Clinical signs in functional cognitive disorders: A systematic review and diagnostic meta-analysis. Journal of Psychosomatic Research, 173, 111447.
Cabreira, V., et al. (2025). Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders. BMJ Neurology Open, 7, e000918.
Cabreira, V., et al. (2025). Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study. European Journal of Neurology, 32, e16318.
Cabreira, V., McWhirter, L., & Carson, A. (2023). Functional cognitive disorder: Diagnosis, treatment, and differentiation from secondary causes of cognitive difficulties. Neurologic Clinics.
Mammì, A., et al. (2026). Neuropsychological assessment in functional cognitive disorder: A scoping review. Psychiatry Research, 117508.
Mavroudis, I., et al. (2025). Functional Cognitive Disorder: Diagnostic challenges, clinical features, and future directions. Frontiers in Aging Neuroscience.
McWhirter, L., & Carson, A. (2023). Functional cognitive disorders: Clinical presentations and treatment approaches. Practical Neurology, 23, 104–110.
McWhirter, L., et al. (2020). Functional cognitive disorders: A systematic review. The Lancet Psychiatry.
Mohan, A., Hayes, C. J., & Krishnan, A. V. (2026). Conceptual frameworks and future directions for functional cognitive disorders in adults: A narrative review and integrative perspective. Current Opinion in Psychiatry, 39, 175–181.
Pennington, C., et al. (2015). Functional cognitive disorder: What is it and what to do about it? Practical Neurology.
Rioux, M., et al. (2024). Pilot feasibility randomized controlled trial of cognitive–behavioral therapy for functional cognitive disorder after concussion. BMJ Neurology Open, 6, e000666.